The tissue factor pathway inhibitor 1 of Sciaenops ocellatus possesses antimicrobial activity and is involved in the immune response against bacterial infection

Developmental and Comparative Immunology

Volumn 35, Issue 3, 2011, Pages 247-252

  Zhang, Min ^a   Sun, Li ^a  

^a INSTITUTE OF OCEANOLOGY   (China)

Author keywords

Antibacterial; Sciaenops ocellatus; Serine protease inhibitor; Tissue factor pathway inhibitor 1

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SYNTHETIC PEPTIDE; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE FACTOR PATHWAY INHIBITOR 1; UNCLASSIFIED DRUG;

ACIDITY; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BLOOD; BRAIN TISSUE; CARBOXY TERMINAL SEQUENCE; CARP; CONTROLLED STUDY; EDWARDSIELLA TARDA; ENZYME INHIBITION; ESCHERICHIA COLI; FISH; GILL; HEART; IMMUNE RESPONSE; INFECTION RESISTANCE; INNATE IMMUNITY; KIDNEY PARENCHYMA; LIVER PARENCHYMA; MUSCLE TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SPLEEN; UPREGULATION; ZEBRA FISH;

BACTERIA (MICROORGANISMS); CYPRINUS CARPIO; DANIO RERIO; ESCHERICHIA COLI; SCIAENOPS; SCIAENOPS OCELLATUS; TELEOSTEI;

EID: 79151482655     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2010.10.006     Document Type: Article

References (40)

1. Bajaj M.S., Birktoft J.J., Steer S.A., Bajaj S.P. Structure and biology of tissue factor pathway inhibitor. Thromb. Haemost. 2001, 86(4):959-972.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
3. Broze G.J. Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood. Coagul. Fibrinolysis 1995, 6(suppl. 1):S7-S13.
4. Camerota A.J., Creasey A.A., Patla V., Larkin V.A., Fink M.P. Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram-negative peritonitis. J. Infect. Dis. 1998, 177(3):668-676.
5. Chand H.S., Du X., Ma D., Inzunza H.D., Kamei S., Foster D., et al. The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice. Blood 2004, 103(3):1069-1077.
6. Creasey A.A., Chang A.C., Feigen L., Wun T.C., Taylor F.B., Hinshaw L.B. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J. Clin. Invest. 1993, 91(6):2850-2860.
7. Cunningham A.C., Hasty K.A., Enghild J.J., Mast A.E. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8. Biochem. J. 2002, 367(Pt2):451-458.
8. Dang W., Zhang M., Hu Y.H., Sun L. Differential regulation of Sciaenops ocellatus viperin expression by intracellular and extracellular bacterial pathogens. Fish. Shellfish Immunol. 2010, 29(2):264-270.
9. Esmon C.T. The interactions between inflammation and coagulation. Br. J. Haematol. 2005, 131(4):417-430.
10. Ettelaie C., Adam J.M., James N.J., Oke A.O., Harrison J.A., Bunce T.D., et al. The role of the C-terminal domain in the inhibitory functions of tissue factor pathway inhibitor. FEBS Lett. 1999, 463(3):341-344.
11. Girard T.J., Warren L.A., Novonty W.F., Likert K.M., Brown S.G., Miletich J.B., et al. Functional significance of the Kuntiz type inhibitor domains of the lipoprotein-associated coagulation inhibitor. Nature 1989, 338(6215):518-520.
12. Hanumanthaiah R., Day K., Jagadeeswaran P. Comprehensive analysis of blood coagulation pathways in teleostei: evolution of coagulation factor genes and identification of zebrafish factor VIIi. Blood Cells Mol. Dis. 2002, 29(1):57-68.
13. Higuchi D.A., Wun T.C., Likert K.M., Broze G.J. The effect of leukocyte elastase on tissue factor pathway inhibitor. Blood 1992, 79(7):1712-1719.
14. Holst J., Lindblad B., Bergqvist D., Nordfang O., Ostergaard P.B., Petersen J.L., et al. Antithrombotic properties of a truncated recombinant tissue factor pathway inhibitor in an experimental venous thrombosis model. Haemostasis 1993, 23(suppl. 1):112-117.
15. Hu Y., Liu C., Hou J., Sun L. Identification, characterization, and molecular application of a virulence-associated autotransporter from a pathogenic Pseudomonas fluorescens strain. Appl. Environ. Microbiol. 2009, 75(13):4333-4340.
16. Hu Y.H., Zheng W.J., Sun L. Identification and molecular analysis of a ferritin subunit from red drum (Sciaenops ocellatus). Fish. Shellfish Immunol. 2010, 28(4):678-686.
17. Kondraganti S., Gondi C.S., Gujrati M., McCutcheon I., Dinh D.H., Rao J.S., et al. Restoration of tissue factor pathway inhibitor (TFPI) inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line. Int. J. Oncol. 2006, 29(1):25-32.
18. Kong D., Ma D., Bai H., Guo H., Cai X., Mo W., et al. Expression and characterization of the first kunitz domain of human tissue factor pathway inhibitor-2. Biochem. Biophys. Res. Commun. 2004, 324(4):1179-1185.
19. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987, 15(20):8125-8148.
20. Levi M., van der Poll T., Büller H.R. Bidirectional relation between inflammation and coagulation. Circulation 2004, 109(22):2698-2704.
21. Lindhout T., Franssen J.O., Willems G. Kinetics of the inhibitor of tissue factor-factor VIIa by tissue factor pathway inhibitor. Thromb. Haemost. 1995, 74(3):910-915.
22. Liu C.S., Sun Y., Zhang M., Sun L. Identification and analysis of a Sciaenops ocellatus ISG15 homologue that is involved in host immune defense against bacterial infection. Fish. Shellfish Immunol. 2010, 29(1):167-174.
23. Lwaleed B.A., Bass P.S. Tissue factor pathway inhibitor: structure, biology and involvement in disease. J. Pathol. 2006, 208(3):327-339.
24. Matyal R., Vin Y., Delude R.L., Lee C., Creasey A.A., Fink M.P. Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shock. Intensive Care Med. 2001, 27(8):1274-1280.
25. Nawroth P.P., Handley D.A., Esmon C.T., Stern D.M. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc. Natl. Acad. Sci. U.S.A. 1986, 83(10):3460-3464.
26. Neuenschwander P.F., Fiore M.M., Morrissey J.H. Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism. J. Biol. Chem. 1993, 268(29):21489-21492.
27. Novotny W.F., Brown S.G., Miletich J.P., Rader D.J., Broze G.J. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood 1991, 78(2):387-393.
28. Osterud B., Rapaport S.I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc. Natl. Acad. Sci. U.S.A. 1977, 74(12):5260-5264.
29. Park C.T., Creasey A.A., Wright S.D. Tissue factor pathway inhibitor blocks cellular effects of endotoxin by binding to endotoxin and interfering with transfer to CD14. Blood 1997, 89(12):4268-4274.
30. Piro O., Broze G.J. Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding. Circulation 2004, 110(23):3567-3572.
31. Price G.C., Thompson S.A., Kam P.C. Tissue factor and tissue factor pathway inhibitor. Anaesthesia 2004, 59(5):483-492.
32. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: a Laboratory Manual 1989, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 2nd ed.
33. Schirm S., Liu X., Jennings L.L., Jedrzejewski P., Dai Y., Hardy S. Fragmented tissue factor pathway inhibitor (TFPI) and TFPI C-terminal peptides eliminate serum-resistant Escherichia coli from blood cultures. J. Infect. Dis. 2009, 199(12):1807-1815.
34. Sierko E., Wojtukiewicz M.Z., Kisiel W. The role of tissue factor pathway inhibitor-2 in cancer biology. Semin. Thromb. Hemost. 2007, 33(7):653-659.
35. Sodeinde O.A., Subrahmanyam Y.V., Stark K., Quan T., Bao Y., Goguen J.D. A surface protease and the invasive character of plague. Science 1992, 258(5084):1004-1007.
36. Wang H., Hu Y., Zhang W., Sun L. Construction of an attenuated Pseudomonas fluorescens strain and evaluation of its potential as a cross-protective vaccine. Vaccine 2009, 27(30):4047-4055.
37. Warshawsky I., Bu G., Mast A., Saffitz J.E., Broze G.J., Schwartz A.L. The carboxy-terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cell in vitro and in vivo. J. Clin. Invest. 1995, 95(4):1773-1781.
38. Wesselschmidt R., Likert K., Girard T., Wun T.C., Broze G.J. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa. Blood 1992, 79(8):2004-2010.
39. Zhang M., Jiao X., Hu Y., Sun L. Attenuation of Edwardsiella tarda virulence by small peptides that interfere with LuxS/autoinducer type 2 quorum sensing. Appl. Environ. Microbiol. 2009, 75(12):3882-3890.
40. Zheng W.J., Hu Y.H., Sun L. Cloning and analysis of a ferritin subunit from turbot (Scophthalmus maximus). Fish. Shellfish Immunol. 2010, 28(5-6):829-836.